Nanomedicine: Downsizing tumour therapeutics

Nature Nanotechnology

Volumn 7, Issue 6, 2012, Pages 346-347

  Cheng, Christopher J ^a   Saltzman, W Mark ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

MEDICAL NANOTECHNOLOGY;

DOXORUBICIN; MACROGOL; NANOPARTICLE; PACLITAXEL;

CANCER THERAPY; DRUG EFFICACY; HYDRODYNAMICS; LIPOSOMAL DELIVERY; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

EID: 84863646104     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2012.89     Document Type: Review

References (7)

1. Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. J. Cell Biol. 188, 759-768 (2010).
2. Matsumura, Y. & Maeda, H. Cancer Res. 46, 6387-6392 (1986).
3. Duggan, S. T. & Keating, G. M. Drugs 71, 2531-2558 (2011).
4. Fang, J., Nakamura, H. & Maeda, H. Adv. Drug Del. Rev. 63, 136-151 (2011).
5. Chauhan, V. et al. Nature Nanotech. 7, 383-388 (2012).
6. Jain, R. K. Science 307, 58-62 (2005).
7. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Mol. Pharm. 5, 505-515 (2008).